Concepedia

Mika Rämet

MR

2

Publications

36

Citations

2

H-Index

2022

Active since

Affiliations

Tampere University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Ben-Gurion University of the Negev

The University of Western Australia

Mika Rämet is an author at Tampere University.

Publications per year

2022–2023

2

Publications

2

Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)

Thomas Benfield, Mika Rämet, Piero Valentini et al. · Vaccine · 2023 · 20 citations · Full text

A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN)

Natalie Banniettis, Jacek Wysocki, Leszek Szenborn et al. · Vaccine · 2022 · 16 citations · Full text

Rows per page

1–2 of 2